Medela Pharmaceuticals Private Limited
About Medela Pharmaceuticals Private Limited
Data last updated:
Medela Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2015PTC287348.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajkumar Singh and Sanjay Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office is at C – 1/51 Sanjay Enclave Uttam Nagar, Delhi, India – 110059.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Medela Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressC – 1/51 Sanjay Enclave Uttam Nagar, Delhi, India – 110059
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medela Pharmaceuticals Private Limited
FY 2016 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2015-16 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Medela Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medela Pharmaceuticals Private Limited
Medela Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajkumar Singh | Director | 10 Nov 2015 | 11 Years 0 Months | Current |
| Sanjay Kumar Singh | Director | 15 Sep 2016 | 10 Years 1 Months | Current |
| Lalita Devi | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Medela Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medela Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medela Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medela Pharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Rajesh Kumar ceased to be Director on 21 Aug 2020.
Frequently asked questions
Medela Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 November 2015 (11+ years old) and is registered under CIN U33110DL2015PTC287348.
Medela Pharmaceuticals has 3 current directors:
- Rajkumar Singh - Director
- Sanjay Kumar Singh - Director
- Lalita Devi - Director
The latest financial statements of Medela Pharmaceuticals on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Medela Pharmaceuticals is U33110DL2015PTC287348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medela Pharmaceuticals was incorporated on 10 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Rajesh Kumar ceased to be Director on 21 Aug 2020. Lalita Devi was appointed as Director on 19 Aug 2020. Sanjay Kumar Singh was appointed as Director on 15 Sep 2016. Medela Pharmaceuticals has 4 board changes on record in total.
The registered office of Medela Pharmaceuticals is at C – 151 Sanjay Enclave Uttam Nagar, Delhi, India – 110059.
Medela Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Medela Pharmaceuticals is active non-compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Medela Pharmaceuticals can be reached at its registered office: C – 151 Sanjay Enclave Uttam Nagar, Delhi, India – 110059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
